Sickle<unk><unk>  affects millions of patients throughout the world. Sickle<unk><unk>  is known to have a high prevalence in Africa (specifically the sub-Saharan region), India, and the Middle East. Worldwide, the current prevalence of sickle<unk><unk>  is 20 million, and nearly 50% of affected people are in Africa. The prevalence of sickle<unk><unk>  in the United States is relatively low; sickle-cell<unk>  affects approximately 100,000 people.
Sickle-cell disease epidemiology and demographics
Statin induced myopathy epidemiology and demographics
Cyanosis epidemiology and demographics
Cryoglobulinemia epidemiology and demographics
Diabetic neuropathy epidemiology and demographics
Sickle-cell disease laboratory findings
Cardiomyopathy epidemiology and demographics
Charcot-Marie-Tooth disease epidemiology and demographics